Variant report
Variant | nsv900382 |
---|---|
Chromosome Location | chr13:66068930-66114004 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534637436 | chr13:66071448-66071449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557622755 | chr13:66071478-66071479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs578007757 | chr13:66071544-66071545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs34733215 | chr13:66071570-66071571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370823332 | chr13:66071572-66071573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537058345 | chr13:66071577-66071578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73512764 | chr13:66071601-66071602 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs574070032 | chr13:66071602-66071603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543118863 | chr13:66071603-66071604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553637651 | chr13:66071634-66071635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181800829 | chr13:66071715-66071716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185271743 | chr13:66071731-66071732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565441108 | chr13:66071737-66071738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138733942 | chr13:66071747-66071748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538404761 | chr13:66071752-66071753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543067699 | chr13:66071819-66071820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563267553 | chr13:66071830-66071831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs117525855 | chr13:66071863-66071864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548655222 | chr13:66071894-66071895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141792512 | chr13:66071937-66071938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs202181921 | chr13:66071947-66071948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112009049 | chr13:66071948-66071949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs34675867 | chr13:66071949-66071950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565582271 | chr13:66071950-66071951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141750896 | chr13:66072030-66072031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551511493 | chr13:66072068-66072069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7329906 | chr13:66072088-66072089 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs7329398 | chr13:66072093-66072094 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs190130982 | chr13:66072099-66072100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182662400 | chr13:66072100-66072101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146235306 | chr13:66072179-66072180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553499856 | chr13:66072257-66072258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533847289 | chr13:66072299-66072300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185078084 | chr13:66072335-66072336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs386771825 | chr13:66072348-66072349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs149901253 | chr13:66072349-66072350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544868403 | chr13:66072438-66072439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563174058 | chr13:66072496-66072497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs4638449 | chr13:66072501-66072502 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs190900856 | chr13:66072531-66072532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs564967347 | chr13:66072580-66072581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9540449 | chr13:66073628-66073629 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs142480429 | chr13:66073639-66073640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369795106 | chr13:66073644-66073645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs373481773 | chr13:66073669-66073670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs572492841 | chr13:66073685-66073686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111670179 | chr13:66073713-66073714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544822604 | chr13:66073766-66073767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552310275 | chr13:66073813-66073814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564995703 | chr13:66073835-66073836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Intellectual disability | 21811512 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 20877625 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:66071400-66071800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr13:66071400-66072200 | Enhancers | NH-A | brain |
3 | chr13:66071600-66072000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr13:66071600-66072000 | Enhancers | Hela-S3 | cervix |
5 | chr13:66071600-66072200 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr13:66071800-66072200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr13:66071800-66072200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
8 | chr13:66072000-66072600 | Enhancers | Placenta Amnion | Placenta Amnion |
9 | chr13:66073600-66074000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr13:66081200-66081400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr13:66081200-66082400 | Enhancers | Muscle Satellite Cultured Cells | -- |
12 | chr13:66081800-66083000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr13:66083000-66083400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr13:66083400-66083600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr13:66083600-66084000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr13:66102400-66103200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr13:66102600-66104600 | Enhancers | Fetal Lung | lung |
18 | chr13:66102800-66103200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
19 | chr13:66102800-66103200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
20 | chr13:66104200-66107400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
21 | chr13:66104400-66105600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
22 | chr13:66104800-66105000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
23 | chr13:66113800-66114800 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
24 | chr13:66113800-66115000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |